Australian pharma urges govt on jobs

19 September 2013

The government can help defend Australia's pharmaceuticals sector employees against further job losses by implementing recommendations of  the Pharmaceuticals Industry Strategy Group's Final Report, the trade  body Medicines Australia's chief executive, Ian Chalmers, has declared.

The report was released on January 30 by the Minister for Innovation,  Industry, Science and Research, Senator Kim Carr. It recommends that  Australian's government sets up a strategic industry investment fund to  support major pharmaceutical manufacturing and R&D activity. and calls  for measures to reverse the nation's declining global competitiveness as  a destination for clinical trials.

"I urge the government to implement the recommendations of this report  without delay. These measures will help defend Australia's  pharmaceuticals industry from further job losses and contribute to its  long-term viability," Mr Chalmers said. "Government inaction on this  issue, especially at this time of economic stress, could have heavy  consequences for the industry and for Australian jobs.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight